Vaccine coverage Americas vs global 2022

Nota: La página que ha solicitado no está en su idioma predeterminado. Usted está usando nuestra plataforma en otro idioma ahora.

As of 2022, around 83 percent of people in the Americas had received the third dose of the Hepatitis B vaccination. Likewise, around 84 percent of people have received the third dose of the HepB vaccination worldwide.

Routine vaccination coverage in the Americas compared to worldwide as of 2022, by vaccine type*

Characteristic	Worldwide total	Americas
BCG	87%	87%
DTP1	89%	90%
DTP3	84%	83%
HepB BD	45%	65%
HepB3	84%	83%
Hib3	76%	83%
HPV last	15%	52%
MCV1	83%	84%
MCV2	74%	76%
PCV3	60%	78%
Pol3	84%	82%
RCV1	68%	84%
Rota last	51%	74%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

October 2023

More information

Region

Worldwide, North America, Central and South America

Survey time period

2022

Supplementary notes

* BCG- Bacillus Calmette-Guérin vaccine
DTP3- third dose of diphtheria and tetanus toxoids and pertussis vaccine
HepB BD- birth dose of hepatitis B vaccine
HepB3- third dose of hepatitis B vaccine
Hib3- third dose of Haemophilus influenzae type b vaccine
MCV1- first dose of measles-containing vaccine
MCV2- second dose of MCV;
PCV3- 3 doses of pneumococcal conjugate vaccine
Pol3- third dose of polio vaccine
RCV- first dose of rubella-containing vaccine; Rota last- final dose of rotavirus vaccination series.
BCG coverage based on 156 countries with BCG in the national schedule; coverage for all other vaccines based on 194 countries (global) or all countries in the specified region.

Citation formats